SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-284569
Filing Date
2022-11-14
Accepted
2022-11-14 16:12:13
Documents
17
Period of Report
2022-11-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d407423d8k.htm   iXBRL 8-K 31693
2 EX-1.1 d407423dex11.htm EX-1.1 308216
3 EX-4.1 d407423dex41.htm EX-4.1 93358
4 EX-5.1 d407423dex51.htm EX-5.1 8289
8 GRAPHIC g407423dsp63.jpg GRAPHIC 9278
9 GRAPHIC g407423dsp64.jpg GRAPHIC 3752
  Complete submission text file 0001193125-22-284569.txt   688948

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rlyb-20221110.xsd EX-101.SCH 2849
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE rlyb-20221110_lab.xml EX-101.LAB 19502
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rlyb-20221110_pre.xml EX-101.PRE 12152
11 EXTRACTED XBRL INSTANCE DOCUMENT d407423d8k_htm.xml XML 3621
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

IRS No.: 851083789 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40693 | Film No.: 221385383
SIC: 2834 Pharmaceutical Preparations